Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Cancer Vaccines 2016 to Feature Talks from Northwest Biotherapeutics, Genentech, Vaccinogen and MSDAgenda released for SMi's 5th annual Cancer Vaccines conference
By: SMi Group Created with a notable panel of industry thought leaders, this year's event will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors and more. Through tactical direction on vaccine commercialisation, the programme will look to strengthen knowledge in overcoming clinical trial failure, offer guidance on passing phase 3 trials and provide attendees with strategic advice for successful vaccine development. SPEAKERS WILL INCLUDE: • Farzin Farzaneh, Professor of Molecular Medicine, Kings College London • Michael G. Hanna Jr, Founder and Chairman Emeritus, Vaccinogen Inc. • Roy Baynes, Senior Vice President and Head, Global Clinical Development, MSD • Christina Derleth, Medical Director, Genentech • Linda Powers, CEO, Northwest Biotherapeutics Inc. • Mustafa Diken, Deputy Vice President of Immunotherapies and Preclinical Research, Biontech RNA Pharmaceuticals GmbH • Andrew Gengos, President & CEO, ImmunoCellular Therapeutics, Ltd. • John Castle, Senior Director, Computational Biology and Genomics, Agenus • Campbell Bunce, SVP Scientific Operations, Abzena Further information including a detailed conference agenda and full speaker line-up is available online. For those looking to attend, there is currently a £400 early bid saving available at http://www.smi- 5th Annual Cancer Vaccines Conference 21st & 22nd September 2016 Holiday Inn Kensington Forum, London UK ---END--- About SMi Group Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|